[HTML][HTML] Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review
SY Lee - BMC Medical Research Methodology, 2024 - Springer
Bayesian statistics plays a pivotal role in advancing medical science by enabling healthcare
companies, regulators, and stakeholders to assess the safety and efficacy of new treatments …
companies, regulators, and stakeholders to assess the safety and efficacy of new treatments …
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias
Introduction The last decade has witnessed major breakthroughs in identifying novel genetic
causes of hereditary ataxias, deepening our understanding of disease mechanisms, and …
causes of hereditary ataxias, deepening our understanding of disease mechanisms, and …
AI-Driven Physical Rehabilitation Strategies in Post-Cancer Care
F Al-Akayleh, M Al-Remawi… - 2024 2nd International …, 2024 - ieeexplore.ieee.org
Artificial intelligence (AI) has made significant progress in addressing the specific obstacles
related to post-cancer physical rehabilitation. This article examines AI technologies such as …
related to post-cancer physical rehabilitation. This article examines AI technologies such as …
[HTML][HTML] Harnessing Big Data in Amyotrophic Lateral Sclerosis: Machine Learning Applications for Clinical Practice and Pharmaceutical Trials
EL Tan, J Lope, P Bede - Journal of Integrative Neuroscience, 2024 - imrpress.com
The arrival of genotype-specific therapies in amyotrophic lateral sclerosis (ALS) signals the
dawn of precision medicine in motor neuron diseases (MNDs). After decades of academic …
dawn of precision medicine in motor neuron diseases (MNDs). After decades of academic …
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis
DV Neel, C Baselga‐Garriga, M Benson… - Muscle & …, 2024 - Wiley Online Library
Abstract Introduction/Aims Expanded access (EA) is a Food and Drug Administration‐
regulated pathway to provide access to investigational products (IPs) to individuals with …
regulated pathway to provide access to investigational products (IPs) to individuals with …
Novel non‐linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods
G Wang, W Wang, B Mangal, Y Liao… - Statistics in …, 2024 - Wiley Online Library
Longitudinal data from clinical trials are commonly analyzed using mixed models for
repeated measures (MMRM) when the time variable is categorical or linear mixed‐effects …
repeated measures (MMRM) when the time variable is categorical or linear mixed‐effects …
Using Bayesian Statistics in Confirmatory Clinical Trials in the Regulatory Setting
SY Lee - arXiv preprint arXiv:2311.16506, 2023 - arxiv.org
Bayesian statistics plays a pivotal role in advancing medical science by enabling healthcare
companies, regulators, and stakeholders to assess the safety and efficacy of new treatments …
companies, regulators, and stakeholders to assess the safety and efficacy of new treatments …